Matthew Klein, CEO of PTC Therapeutics (NASDAQ:PTCT), sold 3,016 shares on January 7th at an average price of $77.48 per share, resulting in a total value of sales amounting to $233,679.68....

Curtiss-Wright Corporation's EVP, John Watts, sold 288 shares on January 8th at an average price of $600 per share, totalling a transaction of $172,800. After the sale, he directly owned 3,188 shares....

Martin Javier San, an insider at Athira Pharma (NASDAQ:ATHA), sold 1,644 shares for a total of $11,310.72 at an average price of $6.88 per share on January 2nd. Post-sale, he owns 10,189 shares....

Kang Jyh Lee, a director at Photronics Inc., sold 8,750 shares on December 22nd for an average price of $34.31 per share. This sale resulted in a total transaction value of $300,212.50....

Cynthia Luccheshi, Director of The Cooper Companies Inc., bought 1,784 shares on December 22nd for a total of $149,963.04 at an average price of $84.06 per share....

Christopher Marlett, an insider at MDB Capital Holdings (NASDAQ:MDBH), bought 4,400 shares on December 30th for an average price of $3.18 per share, totaling $13,992....